KRAS and lung carcinoma: Since A549 cells harbor a mutant KRASG12S allele, we next explored how a TTF-1 transgene would impact the cisplatin sensitivity of another KRAS mutant-containing lung cancer cell line (NCI-H460, KRASQ61H).